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Acute Disseminated Melioidosis Presenting with Septic 
Arthritis and Diffuse Pulmonary Consolidation in an 
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Abstract
Background: Melioidosis is an infectious disease caused by Burkholderia pseudomallei. It is most prevalent in South-East Asia, northern Aus-
tralia, and the Indian subcontinent. Septic arthritis is a rare manifestation of melioidosis. Melioidosis is usually found in patients with diabe-
tes, heavy alcohol use, or chronic lung disease. Case: We report a case of melioidosis in an otherwise healthy 44-year-old male, who presented 
with acute painful left knee swelling, high-grade fever associated with chills, rigors and night sweats, and a productive cough. Examination 
revealed active synovitis with effusion involving his left knee, ankle and elbow joints and scattered crackles over both lung fields. Chest X-ray 
showed diffuse pulmonary consolidation. Abdominal ultrasound showed splenic micro-abscesses. The diagnosis was made based on a positive 
blood culture for Burkholderia pseudomallei. He was started on appropriate antibiotics and responded well, becoming afebrile after 48 hours, 
while his joint effusions disappeared after one week. Conclusion: Septic arthritis only occurs in 4% of patients with melioidosis. When there 
is diffuse pulmonary involvement, melioidosis may mimic disseminated tuberculosis, sepsis syndromes, and systemic vasculitis syndromes. 
This case is relevant for medical literature as melioidosis is emerging and is expanding its territories worldwide. It should be considered early 
in the differential diagnoses in endemic areas so that treatment can be started early to reduce its high mortality and morbidity.
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About the Author: Dr Hai 
Sherng Lee is currently 
working at the Wollongong 
Hospital in New South Wa-
les, Australia. He graduated 
from Monash University 
and was awarded, in his 
final year, “Excellence in 
Pre-Intern Assessment” un-
der the Acute General Sur-
gery Unit at the School of 
Clinical Sciences, Monash 
Health, Victoria, Australia.
Introduction
Melioidosis is an infectious disease caused by the gram-negati-
ve saprophyte Burkholderia pseudomallei. It is most prevalent 
in South-East Asia, northern Australia, and the Indian subconti-
nent.1 It is usually found in patients with diabetes, heavy alco-
hol use, or chronic lung disease.1 The common manifestations 
are pneumonia (in half of all cases), genitourinary infection, 
skin infection, and bacteraemia without evident focus.2 Compli-
cations include septic shock. Recurrent melioidosis is common 
unless long courses of treatment are given, and high mortality 
rates ranging from 14% to 40% have been reported despite 
optimal therapy.1,2
This case is unusual as the patient had none of the risk 
factors known to be associated with this infection and pre-
sented with septic arthritis, which is a rare presenting fea-
ture. It is an uncommon but important disease for clinicians 
to consider as its manifestations are protean, and it can 
mimic many diseases, including pulmonary tuberculosis.1,2 
Melioidosis should be considered as part of the differential 
diagnosis of patients with sepsis or abscesses in endemic 
regions. It is being recognized more frequently in these re-
gions and is one of the important emerging infections that 
clinicians will encounter more in the future.2,3 Informed wri-
tten consent was obtained from the patient for writing and 
publishing this case report.
The Case
A 44-year-old male of Chinese ethnicity, who was previously 
healthy, presented to a district hospital in the state of Johor, 
Malaysia on July 28, 2014, complaining of a one-week his-
tory of acute onset painful swelling of his left knee. He had 
also developed a productive cough with scanty yellowish 
sputum, as well as high-grade fever associated with chills, 
rigors, and night sweats of similar duration. Three days be-
fore hospital admission, his left ankle and elbow joints were 
noted to be swollen and painful. He denied any recent trau-
ma. Findings from a review of his cardiovascular, gastroin-
testinal, and genitourinary systems were normal. His past 
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          Key Points:
• Melioidosis is endemic in tropical regions like South-East Asia and 
northern Australia and is usually found in patients with diabetes, heavy 
alcohol use, or chronic lung disease.
• Septic arthritis is a rare manifestation of melioidosis, found in only 4% 
of the cases at presentation.
• Mortality rates for melioidosis vary from 14% in Australia to 40% in 
northeast Thailand. 
• The standard treatment for melioidosis comprises 10-14 days of intra-
venous ceftazidime or meropenem, followed by oral trimethoprim-sul-
famethoxazole (TMP-SMX) plus doxycycline taken every 12 hours for 3 
to 6 months.
• Melioidosis is becoming an emerging infection and expanding its te-
rritories worldwide. Due to its high mortality and morbidity, it should 
be considered early in the differential diagnoses of patients presenting 
with constitutional symptoms in endemic areas.
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medical history was unremarkable, and there was no family 
history of autoimmune diseases. He denied any recent tra-
vel outside his state and contact with people with active 
pulmonary tuberculosis. He was a current smoker and had 
smoked around 16 cigarette pack-years since the age of 18. 
He drank alcohol only during social events and denied illicit 
drug use and high-risk sexual behaviours. He has worked as 
a tile layer for many years, during which he had occasional 
contact with the soil.
Examination revealed a man of average build, who appea-
red ill and mildly dyspnoeic. Upon admission, his vital signs 
included a pulse rate of 110 beats/min, a blood pressure of 
110/61 mmHg, and a respiratory rate of 24 breaths/min. His 
temperature was 38.5 oC, and there were no pallor, icterus, 
lymphadenopathy, or skin rash noted. Respiratory examination 
revealed only scattered bilateral crackles while a mild hepa-
tosplenomegaly was felt upon abdominal examination. His left 
knee, ankle, and elbow joints showed signs of active synovitis 
with effusion.
Investigations showed a white cell leukocytosis (22.2 x 109/L) 
with neutrophilia (86.4%) and deranged liver function tests 
[alanine transaminase (ALT): 56.2 U/L, aspartate aminotrans-
ferase (AST): 54.7 U/L, and alkaline phosphatase (ALP): 447.2 
U/L]. Other investigations, including urine dipstick and re-
nal profile, were normal. Chest X-ray showed bilateral diffu-
se patchy opacities suggestive of consolidation (Figure 1). 
An ultrasound of his abdomen confirmed mild hepatosple-
nomegaly and multiple irregular small hypo-dense lesions 
scattered in the spleen parenchyma, likely to represent mi-
cro-abscesses. At this point, a working diagnosis of septi-
caemia of unknown focus was made, and he was started on 
intravenous co-amoxiclav to cover the broad spectrum. Spu-
tum samples were sent for acid-fast bacilli to rule out active 
pulmonary tuberculosis and came back negative. A human 
immunodeficiency virus (HIV) screening test was negative. 
He underwent aspiration of his left knee joint effusion, and a 
drainage catheter was inserted (Figure 2). The joint fluid was 
yellowish and clear, with no organisms detected on Gram's 
stain and culture.
On day two of hospital admission, his blood culture grew Bur-
kholderia pseudomallei, leading to the diagnosis of dissemi-
nated melioidosis. He was started on intravenous ceftazidime 
2 g three times daily and two tablets of oral co-trimaxazole 
960 mg twice daily based on sensitivity results. He became 
afebrile after 48 hours, while his joint effusions disappeared 
over the first week of antibiotic treatment. The patient had 
to stay as an inpatient for two weeks for the intensive phase 
of intravenous antibiotic therapy, during which he did not 
develop any complications. A repeat chest X-ray done after 
two weeks of intensive antibiotic therapy showed marked 
radiological improvement (Figure 3). He was discharged home 
after two weeks, with a plan of continuation of oral co-tri-
maxazole for another 20 weeks and outpatient follow-up at 
4-6 weeks intervals. Our patient believed that he acquired 
the infection at his workplace and was satisfied with the 
treatment he received. He understood the protracted nature 
of his illness and was committed to completing his prolonged 
antibiotic therapy.
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Figure 1. Patient’s Chest X-ray, Showing Bilateral Diffuse Patchy 
Opacities Suggestive of Consolidation.
Figure 2. Patient’s Left Knee with Effusion that had been Ban-
daged and Drained.
Figure 3. Patient’s Repeat Chest X-ray After Two Weeks of Anti-
biotics, Showing Marked Radiological Improvement.
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Int J Med Students   •   2015  |  2014 Nov-2015 Mar  |  Vol  3  |  Issue 1 The International Journal of Medical Students 61
Discussion
Melioidosis is caused by the environmental Gram-negative soil 
saprophyte B. pseudomallei. Melioidosis is endemic in Sou-
th-East Asia and northern Australia, with increasing recogni-
tion in the Indian subcontinent and elsewhere in the tropics. 
Northeast Thailand reports the highest number of cases, with 
an annual incidence of 50 cases per 100,000 people, making 
melioidosis the third most common cause of death due to 
infectious diseases in northeast Thailand.1 In Darwin, tropical 
Australia, a 20-year prospective study from October 1989 yiel-
ded 540 cases of melioidosis.2 Melioidosis has been studied 
extensively only in certain regions of Malaysia where there is 
known to be a higher incidence of disease. For instance, there 
were 44 new cases of melioidosis in the Malaysian state of 
Johor between January 1999 and December 2003.4 Melioidosis 
is an emerging disease, as evidenced by increased reported 
incidence in endemic regions. For example, in Darwin, the 
prospective study identified 88 cases in the first five years, 
which increased steadily to 149 cases in the final five years.2 
In Northeast Thailand, there were 198 cases in 1997, which 
increased to 380 cases in 2006.3 In addition, cases are being 
identified in new areas where melioidosis has not previously 
been reported.1
The primary modes of transmission of melioidosis are thought 
to be percutaneous inoculation in persons who are in regular 
contact with soil and water and, less commonly, via inhala-
tion during severe stormy weather or by ingestion of contami-
nated food or water.1 Melioidosis is predominantly seasonal, 
and more than 75% of cases occur during the rainy season. B. 
pseudomallei can invade macrophages and survive and repli-
cate for extended periods of time. Phagocytes may be able to 
destroy the bacteria, but some bacteria can escape endocytic 
vacuoles and enter into the cytoplasmic space. They are also 
capable of infecting other cells through actin-based membrane 
protrusions.1
Melioidosis has a wide array of clinical signs and symptoms. It 
has an incubation period of 1-21 days, with a mean of 9 days, 
although prolonged periods of latency (up to 62 years) have 
been reported.1 Its severity varies from an acute fulminant sep-
tic illness to a chronic infection, in which symptoms last for 
more than two months and may mimic malignancy or tubercu-
losis. In a descriptive study done over 20 years in tropical Aus-
tralia, the most common presenting feature was pneumonia, 
which was present in 50% of cases, followed by genitourinary 
infection, skin infection, and bacteraemia without evident fo-
cus.2 Septic arthritis, which was the principal presentation of 
our patient, and septic osteomyelitis are rare presenting fea-
tures, with only 4% of cases having such manifestations. Over 
half of patients have bacteraemia on presentation, and septic 
shock develops in approximately one fifth. Internal-organ abs-
cesses and secondary foci in the lungs, skin and soft tissues, 
bones and joints, or any other organ may occur. Up to 80% of 
patients with melioidosis have one or more risk factors for the 
disease, which include diabetes, heavy alcohol use, chronic 
pulmonary disease, chronic kidney disease, and thalassaemia. 
Glucocorticoid therapy and cancer were only associated in less 
than 5% of cases.1-3 Our patient, however, had no such known 
risk factors.
The diagnosis of melioidosis is made from a positive culture 
for B. pseudomallei from any clinical sample, which in our 
patient’s case was a positive blood culture. We would have 
faced diagnostic difficulties if the culture had been negati-
ve due to the non-availability of serological or genetic-based 
testing at the hospital where the patient was treated. But the 
delay in the identification of B. pseudomallei or misidentifi-
cation as another species is not uncommon in laboratories 
that are unfamiliar with this organism.5 A direct polymera-
se-chain-reaction assay of a clinical sample may be useful 
to provide a more rapid result than culture, but the assay 
is less sensitive, especially when performed on blood sam-
ples.6 Serologic testing alone is not adequate to confirm the 
diagnosis, especially in endemic regions where background 
seropositivity is common.7 The treatment of melioidosis inclu-
des prolonged courses of appropriate antibiotics due to the 
recalcitrant nature of the infection. An initial intensive phase 
should include at least 10 to 14 days of intravenous cefta-
zidime or meropenem followed by oral eradication therapy, 
which comprises trimethoprim-sulfamethoxazole (TMP-SMX) 
taken every 12 hours for 3 to 6 months, with or without doxy-
cyline.5 TMP-SMX plus doxycycline is considered the standard 
oral eradication regimen, although one recent study showed 
that TMP-SMX alone is not inferior to TMP-SMX with doxycy-
cline.8 Amoxicillin–clavulanate can be used as an alternative 
agent for eradication therapy when there are contraindica-
tions for the use of TMP-SMX.9
Mortality rates in melioidosis vary from region to region. For 
instance, it is approximately 40% in northeast Thailand,5 but 
14% in Australia.2 Recurrent melioidosis occurs in approxima-
tely 1 in 16 patients, often in the first year after the initial 
presentation. Nearly 25% of recurrences are due to reinfection, 
with the remainder due to relapses from a persistent focus of 
infection.10
In conclusion, septic arthritis only occurs in 4% of patients 
presenting with melioidosis.2 When there is diffuse pulmonary 
involvement, it may mimic disseminated tuberculosis, other 
acute disseminated or focal sepsis syndromes, and systemic 
vasculitis syndromes.1,2 This case is relevant to the medical 
literature as melioidosis is becoming an emerging infection and 
expanding its territories worldwide. It should be considered 
early in the differential diagnoses of patients presenting with 
constitutional symptoms in areas where it is known to be en-
demic so that treatment can be started early to reduce its high 
mortality and morbidity.2,3
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